Literature DB >> 28763197

Cyclodextrin/Paclitaxel Dimer Assembling Vesicles: Reversible Morphology Transition and Cargo Delivery.

Qing Pei1,2, Xiuli Hu1, Lei Wang1, Shi Liu1, Xiabin Jing1, Zhigang Xie1.   

Abstract

Here, we developed stable supramolecular binary vesicles on the basis of the host-guest interaction between β-cyclodextrins (β-CDs) and paclitaxel (PTX) dimer. The inclusion complexation between PTX dimer and β-CDs in water was studied by proton nuclear magnetic resonance spectroscopy and two-dimensional rotating-frame Overhauser effect spectroscopy. The resulting inclusion complex was amphiphilic and could self-assemble into vesicles with average diameter of 230 nm. The vesicles could evolve to nanoparticles (NPs) by adding competitive binding guest amantadine hydrochloride or by digesting β-CDs through α-amylase. Moreover, this process was reversible, and the NPs could also transform to vesicles by adding enough β-CDs again. The obtained hollow supramolecular vesicles were further explored to load hydrophilic dye indocyanine green molecule or hydrophobic anticancer drug doxorobicin for their controlled release under external stimulus. This work provides a new strategy for the design of supramolecular systems by using prodrug as building blocks.

Entities:  

Keywords:  drug delivery; host−guest complexation; reversible structure transition; supramolecular; vesicles

Mesh:

Substances:

Year:  2017        PMID: 28763197     DOI: 10.1021/acsami.7b08110

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

Review 1.  Disulfide based prodrugs for cancer therapy.

Authors:  Qiang Wang; Jiankun Guan; Jiangling Wan; Zifu Li
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036

Review 2.  A Promising Review on Cyclodextrin Conjugated Paclitaxel Nanoparticles for Cancer Treatment.

Authors:  Kamini Velhal; Sagar Barage; Arpita Roy; Jaya Lakkakula; Ramesh Yamgar; Mohammed S Alqahtani; Krishna Kumar Yadav; Yongtae Ahn; Byong-Hun Jeon
Journal:  Polymers (Basel)       Date:  2022-08-03       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.